| pubmed-article:20506089 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20506089 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:20506089 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:20506089 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:20506089 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
| pubmed-article:20506089 | lifeskim:mentions | umls-concept:C0034975 | lld:lifeskim |
| pubmed-article:20506089 | lifeskim:mentions | umls-concept:C0241315 | lld:lifeskim |
| pubmed-article:20506089 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:20506089 | pubmed:dateCreated | 2010-5-27 | lld:pubmed |
| pubmed-article:20506089 | pubmed:abstractText | We created a registry to evaluate long term outcome, efficacy and adverse events for children treated wit TNF-alpha inhibitors in Switzerland. 106 patients (68 female/38 male) were included. 61 patients were treated with Etanercept (Enbrel) and 45 with Infliximab (Remicade). Concomitant treatment at baseline included corticosteroids in 26% and Methotrexate in 75% of the patients. Subjective disease activity three months after initiation of TNF-alpha was better in 81%, worse in 4% and stable in 15% of the patients. In total 24 adverse events in 21 patients were reported. Treatment with TNF-alpha inhibitors seems to be safe and effective for children and adolescents with rheumatologic diseases. | lld:pubmed |
| pubmed-article:20506089 | pubmed:language | ger | lld:pubmed |
| pubmed-article:20506089 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20506089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20506089 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20506089 | pubmed:month | May | lld:pubmed |
| pubmed-article:20506089 | pubmed:issn | 1661-8157 | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:KaiserDD | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:BoltJJ | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:HoferMM | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:SauvainM JMJ | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:CannizzaroEE | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:SaurenmannR... | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:SchalmS BSB | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:BérthetGG | lld:pubmed |
| pubmed-article:20506089 | pubmed:author | pubmed-author:BoltI BIB | lld:pubmed |
| pubmed-article:20506089 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20506089 | pubmed:day | 26 | lld:pubmed |
| pubmed-article:20506089 | pubmed:volume | 99 | lld:pubmed |
| pubmed-article:20506089 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20506089 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20506089 | pubmed:pagination | 649-54 | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:meshHeading | pubmed-meshheading:20506089... | lld:pubmed |
| pubmed-article:20506089 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20506089 | pubmed:articleTitle | [Swiss registry for TNF-alpha blockers in children and adolescents with rheumatological diseases]. | lld:pubmed |
| pubmed-article:20506089 | pubmed:affiliation | Unikinderklinik für Kinderheilkunde+Uniklinik für Rheumatologie, Klinische Immunologie+Allergologie, Inselspital, Universitätsspital Bern. | lld:pubmed |
| pubmed-article:20506089 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20506089 | pubmed:publicationType | English Abstract | lld:pubmed |
